Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of academic performance of premedical students to satisfaction and engagement in a short training program: a cross sectional study presenting gender differences.
Bigna JJ, Fonkoue L, Tchatcho MF, Dongmo CN, Soh DM, Um JL, Sime PS, Affana LA, Woum AR, Noumegni SR, Tabekou A, Wanke AM, Taffe HR, Tchoukouan ML, Anyope KO, Ella SB, Mouaha BV, Kenne EY, Mbessoh UI, Tchapmi AY, Tene DF, Voufouo SS, Zogo SM, Nouebissi LP, Satcho KF, Tchoumo WJ, Basso MF, Tcheutchoua BD, Agbor AA. Bigna JJ, et al. Among authors: noumegni sr. BMC Res Notes. 2014 Feb 24;7:105. doi: 10.1186/1756-0500-7-105. BMC Res Notes. 2014. PMID: 24564911 Free PMC article.
Predictors of Recurrent Venous Thromboembolism or Arterial Thrombotic Events during and after Anticoagulation for a First Venous Thromboembolism.
Noumegni SR, Tromeur C, Hoffmann C, Mao RL, Moigne EL, Moreuil C, Mansourati V, Nasr B, Gentric JC, Guegan M, Poulhazan E, Bressollette L, Lacut K, Didier R, Couturaud F. Noumegni SR, et al. Semin Thromb Hemost. 2023 Oct;49(7):688-701. doi: 10.1055/s-0042-1757899. Epub 2022 Oct 17. Semin Thromb Hemost. 2023. PMID: 36252603
Risk Factors for Major Adverse Cardiovascular Events and Major Adverse Limb Events after Venous Thromboembolism: A Large Prospective Cohort Study.
Noumegni SR, Didier R, Mansourati V, Moigne EL, Mao RL, Hoffmann C, Moreuil C, Tromeur C, Roux PL, Nasr B, Gentric JC, Guegan M, Poulhazan E, Lacut K, Bressollette L, Couturaud F. Noumegni SR, et al. Semin Thromb Hemost. 2022 Jun;48(4):465-480. doi: 10.1055/s-0042-1748152. Epub 2022 Jun 30. Semin Thromb Hemost. 2022. PMID: 35772402
Anticoagulation for VTE: Impact on the Risk of Major Adverse Cardiovascular Events.
Noumegni SR, Le Mao R, de Moreuil C, Hoffmann C, Le Moigne E, Tromeur C, Mansourati V, Nasr B, Gentric JC, Guegan M, Poulhazan E, Bressollette L, Lacut K, Didier R, Couturaud F. Noumegni SR, et al. Chest. 2022 Nov;162(5):1147-1162. doi: 10.1016/j.chest.2022.05.038. Epub 2022 Jun 15. Chest. 2022. PMID: 35714709
Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
Noumegni SR, Didier R, Mansourati V, Tromeur C, Le Moigne E, Hoffmann C, Nasr B, Gentric JC, Guegan M, Poulhazan E, Lacut K, Bressollette L, Le Mao R, Couturaud F. Noumegni SR, et al. Thromb Res. 2022 Jun;214:93-105. doi: 10.1016/j.thromres.2022.04.016. Epub 2022 Apr 29. Thromb Res. 2022. PMID: 35525202
19 results